Pour savoir comment effectuer et gérer un dépôt de document, consultez le « Guide abrégé – Dépôt de documents » sur le site Web de la Bibliothèque. Pour toute question, écrivez à corpus@ulaval.ca.
 

Personne :
Vincent, Flavien

En cours de chargement...
Photo de profil

Adresse électronique

Date de naissance

Projets de recherche

Structures organisationnelles

Fonction

Nom de famille

Vincent

Prénom

Flavien

Affiliation

Université Laval

ISNI

ORCID

Identifiant Canadiana

ncf13674405

person.page.name

Résultats de recherche

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
PublicationRestreint

Impact of left ventricular dysfunction in patients with high and low gradient severe aortic stenosis following transcatheter aortic valve replacement

2020-11-04, Alperi, Alberto, Faroux, Laurent, Ternacle, Julien, Muntane Carol, Guillem, De Larochellière, Robert, Paradis, Jean-Michel, Kalavrouziotis, Dimitri, Mohammadi, Siamak, Beaudoin, Jonathan, Bernier, Mathieu, Dumont, Éric, Côté, Nancy, Côté, Mélanie, Vincent, Flavien, Clavel, Marie-Annick, Rodés-Cabau, Josep, Pibarot, Philippe

Background: Outcomes of transcatheter aortic valve replacement (TAVR) in patients with high-gradient (HG) severe aortic stenosis (AS) and reduced left-ventricular (LV) ejection fraction (EF) are unknown. Methods: Patients undergoing TAVR for native severe AS between 2009 and 2018 were retrospectively included and classified into 3 groups: HG (≥ 40 mm Hg) and preserved EF (≥ 50%), HG low EF (< 50%), and low gradient (LG < 40 mm Hg) low EF. The primary endpoint was a composite of cardiovascular mortality and readmission for heart failure at 1 year after TAVR. Results: Of the 526 patients included, 323 (61%) had HG preserved EF, 69 (13%) had HG low EF, and 134 (26%) had LG low EF. HG low EF group had higher prevalence of atrial fibrillation and heart failure and higher Society of Thoracic Surgeons score compared with the HG preserved EF group. Patients in the LG low EF group were older and had higher prevalence of coronary artery disease compared with those in the HG groups. All-cause mortality at 30 days (4.0%) was similar across the 3 groups. After adjustment, the risk of primary endpoint was similar in the HG low-EF vs preserved EF groups. Conversely, the risk of primary endpoint was higher in the LG low EF group vs the HG preserved EF group (hazard ratio [HR], 2.24; 95% confidence interval [CI],1.36-3.70; P = 0.002) and vs HG low EF group (HR, 3.50; 95% CI, 1.55-7.90; P = 0.003), whereas the risk of all-cause mortality was similar across the 3 groups. Conclusions: The outcome of patients with HG low EF severe AS following TAVR is as good as that of patients with HG preserved EF